Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and clemastine for remyelination in RRMS
NCT05131828Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs), clemastine in multiple sclerosis (MS), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Mar 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)clemastine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05131828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05131828.